Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) — Cash Flow-to-Debt Ratio
Shaanxi Meibang Pharmaceutical Group Co Ltd (605033) has a Cash Flow-to-Debt Ratio of 0.37x as of September 2025, meaning its operating cash flow of CN¥281.88 Million could theoretically repay 0% of its total liabilities (CN¥757.69 Million) in one year. See 605033 FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shaanxi Meibang Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (2017–2024)
Historical debt coverage capacity for Shaanxi Meibang Pharmaceutical Group Co Ltd across 8 annual periods. Also explore Shaanxi Meibang Pharmaceutical Group Co (605033) net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shaanxi Meibang Pharmaceutical Group Co Ltd (2017–2024)
Year-by-year debt coverage analysis for Shaanxi Meibang Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see how much is Shaanxi Meibang Pharmaceutical Group Co worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.38x | CN¥280.40 Million | CN¥737.37 Million | ▼ -34.4% |
| 2023 | 0.58x | CN¥334.79 Million | CN¥577.84 Million | ▲ +117.3% |
| 2022 | 0.27x | CN¥126.41 Million | CN¥474.14 Million | ▲ +221.7% |
| 2021 | -0.22x | CN¥-108.75 Million | CN¥496.43 Million | ▼ -198.5% |
| 2020 | 0.22x | CN¥74.88 Million | CN¥336.50 Million | ▼ -48.8% |
| 2019 | 0.43x | CN¥128.45 Million | CN¥295.34 Million | ▲ +693.5% |
| 2018 | 0.05x | CN¥16.96 Million | CN¥309.40 Million | ▼ -38.6% |
| 2017 | 0.09x | CN¥29.41 Million | CN¥329.23 Million | — |